Tumor microenvironment-specific nanomedicine: from biology-driven to multi-omics-guided precision engineering
Tumor microenvironment-specific nanomedicine: from biology-driven to multi-omics-guided precision engineering
J. Hematol. Oncol., DOI: 10.1186/s13045-026-01811-9
Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor-Ligand Interactions
Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor-Ligand Interactions
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma
Clin. Cancer Res., DOI: 10.1158/1078-0432.CCR-26-0273
Enhanced endosomal escape for nanoparticle-enabled co-delivery of doxorubicin and siRNA to overcome multidrug resistance
Enhanced endosomal escape for nanoparticle-enabled co-delivery of doxorubicin and siRNA to overcome multidrug resistance
A Co-opted Developmental Gene Regulatory Program in Endothelial Progenitors Promotes Tumor Angiogenic Phenotypes
A Co-opted Developmental Gene Regulatory Program in Endothelial Progenitors Promotes Tumor Angiogenic Phenotypes
Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers
Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers